Cite
MLA Citation
Jane C Burns et al.. “Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.” Lancet, vol. 5, 2021, pp. 852–861. http://access.bl.uk/ark:/81055/vdc_100146097784.0x00000c